Publikationen von C. T. Wotjak

Siegmund, A.; Wotjak, C. T.: Toward an animal model of posttraumatic stress disorder. In: PSYCHOBIOLOGY OF POSTTRAUMATIC STRESS DISORDER: A DECADE OF PROGRESS, S. 324 - 334 (Hg. Yehuda, R.). BLACKWELL PUBLISHING, OXFORD (2006)

Wotjak, C. T.: Learning and Memory. In: Anxiety and Anxiolytic Drugs, S. 1 - 34 (Hg. Holsboer, F.; Ströhle, A.). Springer, Berlin (2005)

Engelmann, M.; Wotjak, C. T.; Landgraf, R.: Differential central and peripheral release of vasopressin and oxytocin in response to swim stress in rats. In: Vasopressin and Oxytocin. Advances in Experimental Medicine and Biology, Vol. 449, S. 175 - 177 (Hg. Zingg, H. H.; Bourque, C. W.; Bichet, D. G.). Plenum Press, New York (1998)

Landgraf, R.; Kubota, M.; Holsboer, F.; Wotjak, C. T.: Release of vasopressin and oxytocin within the brain and into blood: microdialysis and antisense targeting. In: Neurohypophysics: Recent Progress of Vasopressin and Oxytocin Research, S. 234 - 256 (Hg. Saito, T.; Kurokawa, K.; Yushido, S.). Elsevier, Amsterdam (1995)

Almeida-Correa, S.; Bedenk, B. T.; Bura, S.; Genewsky, A.; Dine, J.; Czisch, M.; Wotjak, C. T.: Spatial learning matrix in vivo identification via functional Mn-enhanced MRI and voxel-wise whole brain analysis in mice. European College of Neuropsychopharmacology (ECNP) Workshop for Junior Scientists in Europe, Nice, FRANCE, 09. März 2017 - 12. März 2017. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (S1), P.2.021, S. S42 - S43 (2017)

Wotjak, C. T.: Ethobehavioral assessment of innate fear and what endocannabinoids have got to do with it. Conference of the World Association for Stress Related and Anxiety Disorders (WASAD), Würzburg, GERMANY, 14. September 2017 - 16. September 2017. JOURNAL OF NEURAL TRANSMISSION 124 (10), S. 1291 - 1291 (2017)

von Rueden, E.-L.; Bogdanovic, R. M.; Potschka, H.; Wotjak, C.: INDIRECT ACTIVATION OF THE ENDOCANNABINOID SYSTEM: 2-ARACHIDONOYLGLYCEROL MEDIATES CANNABINOID-DEPENDENT EFFECTS IN A MOUSE MODEL OF TEMPORAL LOBE EPILEPSY. 11th European Congress on Epileptology, Stockholm, SWEDEN, 29. Juni 2014 - 03. Juli 2014. EPILEPSIA 55 (Supplement s2), S. 193 - 194 (2014)

Sander, A.; Rammes, G.; Preis, L.; Wotjak, C.; Jungwirth, B.; Ebert, T.: Interactions of the inhalative anaesthetics xenon, desflurane and sevoflurane with the a beta-derived cognitive deficits in an Alzheimer's disease (AD) mouse. In European Neuropsychopharmacology, 29, S. S134 - S134. 32nd Congress of the European-College-of-Neuropsychopharmacology (ECNP), Copenhagen, DENMARK, 07. September 2019 - 10. September 2019. Elsevier, Amsterdam (2019)

Dedic, N.; Kühne, C.; Gomes, K.; Anderzhanova, E.; Hartmann, J.; Schmid, B.; Kolarz, A.; Vogl, A. M.; Wotjak, C. T.; Grinevich, V. et al.; Binder, E.; Chen, A.; Schmidt, M. V.; Wurst, W.; Refojo, D.; Deussing, J. M.: CRH Acts Anxiolytic by Modulating Dopamine Release through a Subset of GABAergic Long-range Projection Neurons. In NEUROPSYCHOPHARMACOLOGY, 40, S. S314 - S314. 54th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP), Hollywood, FL, 06. Dezember 2015 - 10. Dezember 2015. Nature Publishing Group, LONDON N1 9XW, ENGLAND (2015)

Wotjak, C.: Untersuchungen zur Vasopressin-Freisetzung in ausgewählten Kerngebieten des Rattengehirns unter besonderer Berücksichtigung des parvozellulären vasopressinären Systems. Dissertation, Ludwig-Maximilians-Universität, München (1995)

Stark, T.; Di Martino, S.; Drago, F.; Wotjak, C. T.; Micale, V.: Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment. PHARMACOLOGICAL RESEARCH 174, 105938 (2021)

Haaker, J.; Maren, S.; Marta, A.; Merz, C. J.; Richter, J.; Helene, R. S.; Shira, M. D.; Lange, M. D.; Kay, J.; Nees, F. et al.; Seidenbecher, T.; Fullana, M. A.; Wotjak, C. T.; Lonsdorf, T. B.: Making translation work: Harmonizing cross-species methodology in the behavioural neuroscience of Pavlovian fear conditioning. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS 107, S. 329 - 345 (2019)

Wotjak, C. T.: Sound check, stage design and screen plot - how to increase the comparability of fear conditioning and fear extinction experiments. PSYCHOPHARMACOLOGY 236 (1), S. 33 - 48 (2019)

Hahn, C.; Becker, K.; Saghafi, S.; Pende, M.; Avdibasic, A.; Foroughipour, M.; Heinz, D. E.; Wotjak, C. T.; Dodt, H.-U.: High-resolution imaging of fluorescent whole mouse brains using stabilised organic media (sDISCO). JOURNAL OF BIOPHOTONICS 12 (8), UNSP e201800368 (2019)